Current through Register Vol. 49, No. 2, January 10, 2025
Section 335.9120 - Training for Ophthalmic Use of Strontium-90Except as provided in Section 335.9160, the licensee shall require the authorized user using only strontium-90 for ophthalmic radiation therapy to be a physician who:
a) Is an authorized user who meets the requirements of Section 335.9100 or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements; orb) Has: 1) Completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiation therapy. The training shall include: A) Radiation physics and instrumentation;C) Mathematics pertaining to the use and measurement of radioactivity;D) Radiation biology; and2) Completed clinical training in ophthalmic radiation therapy under the supervision of an authorized user at a medical institution, clinic, or private practice that includes the use of strontium-90 for the ophthalmic treatment of 5 individuals. The supervised clinical training shall include:A) Examination of each individual to be treated;B) Calculation of the dose to be administered;C) Administration of the dose; andD) Follow-up and review of each individual's case history; and3) Obtained written attestation that the individual has satisfactorily completed the requirements in subsections (b)(1) and (b)(2) and is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use. The attestation shall be signed by a preceptor authorized user who meets the requirements in this Section, Section 335.9100, 335.9160, or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements.Ill. Admin. Code tit. 32, § 335.9120
Amended at 35 Ill. Reg. 884, effective December 30, 2010
Amended at 46 Ill. Reg. 966, effective 12/21/2021